Keywords: اینترلوکین; TB; tuberculosis; M.tb; Mycobacterium tuberculosis; PM; particulate matter; PM10; particulate matter with an aerodynamic diameter of <10 μm; PM2.5; Particulate matter with an aerodynamic diameter of <2.5 μm; CO; carbon monoxide; NO2; nitrogen dioxide;
مقالات ISI اینترلوکین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترلوکین; COX-2; cyclooxygenase-2; DOCA; deoxycorticosterone acetate; FOX1; ferrous ion oxidation by xylenol orange reagent; FRAP; ferric reducing antioxidant power; H & E; hematoxylin and eosin; H2O2; hydrogen peroxide; IL; interleukin; MDA; malondialdehyde; NADPH
Keywords: اینترلوکین; COPD; chronic obstructive pulmonary disease; O3; ozone; BUD; budesonide; BALF; bronchoalveolar lavage fluid; MMP; matrix metalloproteinase; HIF-1α; hypoxia-inducible factor-1α; VEGF; vascular endothelial growth factor; α-SMA; α-smooth muscle actin; GS
Keywords: اینترلوکین; Diabetes mellitus; Diabetic foot ulcer; Photobiomodulation; Reverse transcription-polymerase chain reaction; Conditioned medium; Histology; Stereology; Rat; Mesenchymal stem cell; Human bone marrow; Low-level laser therapy; Adipose-derived stem cells cond
Keywords: اینترلوکین; Biotherapeutics; Gene and cell therapy; Pharmacokinetics; Non-clinical safety; Immunogenicity; Cross-reactive species; ATMP; advanced therapy medicinal products; CAR; chimeric antigen receptor; CD; cluster of differentiation; CMC; chemistry manufacturing
Keywords: اینترلوکین; Resistin-like molecule; Macrophage; Helminth infection; T helper type 2; Toll-like Receptor 4; ABC; ATP-binding cassette transporter; ADD1; adipocyte determination and differentiation dependent factor 1; ADSF; adipocyte secreted factor; Akt (aka PKB); pro
Keywords: اینترلوکین; AGE; advanced glycation end products; AICAR; 5-Aminoimidazole-4-carboxamide ribonucleotide; AMPK; 5â² adenosine monophosphate-activated protein kinase; APC; antigen-presenting cell; Atg7; autophagy-related gene 7; ATP; adenosine triphosphate; ATRA; all-t
Keywords: اینترلوکین; AT; adipose tissue; BM; bone marrow; CsA; cyclosporine A; COX-2; cyclooxygenase-2; DEX; dexamethasone; DMEM; Dulbeccós modified Eaglés medium; DMSO; dimethyl sulfoxide; ELISA; enzyme-linked immunosorbent assay; FasL; Fas ligand; HGF; hepatocyte growth f
Keywords: اینترلوکین; BMP; bone morphogenetic protein; CCL; chemokine (C-C motif) ligand; CCR; chemokine receptor; CM; conditioned medium; CXCR; CXC chemokine receptors; DAMP; damage-associated molecular patterns; ECM; extracellular matrix; EV; extracellular vesicle; FGF; fibr
Keywords: اینترلوکین; Adipocyte; Breast cancer; Tumor-stroma interaction; CAF; cancer-associated fibroblast; WAT; white adipose tissue; CLS; crown-like structure; CAA; cancer-associated adipocyte; ECM; extracellular matrix; IL; interleukin; ER; estrogen receptor; TNBC; triple-
Keywords: اینترلوکین; Cardiovascular diesease; Dipeptidyl peptidase 4 inhibitor; Atherosclerosis; Heart failure; Myocardial infarction; AMI; acute myocardial infarction; BNP; Brain natriuretic peptide; CD26; cluster of differentiation 26; CHD; coronary heart disease; CKD; chro
Keywords: اینترلوکین; cardiovascular; comorbidity; environment; gastrointestinal; genetics; immune; microbiome; neurologic; pathophysiology; rosacea; CeD; celiac disease; CVD; cardiovascular disease; GST; glutathione-S-transferase; GWAS; genome-wide association study; HLA; hum
Keywords: اینترلوکین; Anticoagulants; Cytokine; Luminex; Validation; Serum; Plasma; IL; interleukin; CC; CC-chemokine (beta chemokine); CXC; CXC-chemokine (alpha chemokine); XC; C-chemokine (gamma chemokine); TNF; tumor necrosis factor; IFN; interferon; LIGHT; homologous to ly
Keywords: اینترلوکین; Gut Bacteria; Immune Regulation; Tumor Promotion; Metastases; IFN; interferon; IL; interleukin; Th; T-helper cell; TME; tumor microenvironment;
Keywords: اینترلوکین; Glucocorticoids; Opioid receptors; Pituitary-adrenal system; Psychological stress; Regulatory T lymphocytes; ACC; anterior cingulate cortex; β2AR; β2-adrenergic receptor; ACTH; adrenocorticotropic hormone; ADCYAP1R1; adenylate cyclase-activating polypep
Keywords: اینترلوکین; CP; cerebral Palsy; CSF; cerebrospinal fluid; HI; hypoxia-ischemia; HIE; hypoxic-ischemic encephalopathy; hAECs; human amnion epithelial cells; MCAO; middle cerebral artery occlusion; MSCs; mesenchymal stem cells; MRI; magnetic resonance imaging; NSCs; ne
Keywords: اینترلوکین; Co; cardiac output; EE; energy expenditure; GLUT4; glucose transporter type 4; Hr; heart rate; IL; interleukin; Vo2; oxygen consumption; Burn injury; Critical care; Hypermetabolism; Hypercatabolism; Micronutrients; Glutamine; Quemados; Cuidados crÃticos;
Keywords: اینترلوکین; 11βHSD; 11β-Hydroxysteroid dehydrogenase; ABC; ATP-binding cassette; AhR; aryl hydrocarbon receptor; ARNT; aryl hydrocarbon receptor nuclear translocator; BCRP; breast cancer resistance protein; CAR; constitutive androstane receptor; CYP; cytochrome P45
Keywords: اینترلوکین; ANOVA; Analysis of variance; ASM; Airway smooth muscle; BALF; Bronchoalveolar lavage fluid; cDNA; Complementary DNA; COL1α1; Collagen, type I, alpha 1; CON; Conventional chronic model/protocol; H&E; Hematoxylin and eosin; IL; Interleukin; MMP-9; Matrix m
Keywords: اینترلوکین; BD; bipolar disorder; IL-17; interleukin-17; YMRS; young mania rating scale; HDRS; hamilton depression rating scale; CSSR; Columbia suicide severity rating scale; DSM-IV TR; diagnostic and statistical manual of mental disorders, edition IV-text revised;
Keywords: اینترلوکین; Bamboo-shaving polysaccharide (BSP); Prebiotic; Gut microbiota; Inflammation; Obesity; Insulin resistance; BSP; bamboo-shaving polysaccharide; IL; interleukin; TNF-α; tumor necrosis factor alpha; MCP-1; monocyte chemoattractant protein-1; LPS; lipopolysa
Keywords: اینترلوکین; ADAM; a disintegrin and metalloproteinase; APP; amyloid precursor protein; APC; antigen presenting cell; Aβ; β-amyloid; B7-H1; B7-homolog 1; CARD; caspase activation and recruitment domain; CCR; C-C chemokine receptor; CIM; C-protein induced myositis; C
Keywords: اینترلوکین; α-CGRP; alpha-calcitonin gene related peptide; Ang; angiopoietin; AE2; anion exchanger 2; ADP; adenosine diphosphate; ADPKD; autosomal dominant polycystic kidney disease; ATP; adenosine triphosphate; ASBT; sodium-dependent bile acid transporter; AQP; aqu
Keywords: اینترلوکین; physical signs; pathophysiology; treatment; BMT; Bone marrow transplantation; CyA; Cyclosporine A; HCQ; Hydroxychloroquine; HLA; Human leukocyte antigen; IL; Interleukin; IVIG; Intravenous immunoglobulin therapy; JDM; Juvenile dermatomyositis; JM; Juvenil
Keywords: اینترلوکین; DEE; drug-eluting embolic; FdUrd-C8; 3â²,5â²-dioctanoyl-5-fluoro-2â²-deoxyuridine; HCC; hepatocellular carcinoma; IL; interleukin; LRT; locoregional therapy; MN-16ET; N-[2-(triphenylmethyl)thioethyl]-3-aza-19-ethyloxycarbonyl-3-[2-(triphenylmethyl)thio
Keywords: اینترلوکین; oral thyroxin; infants; postoperative cardiac index; CI; cardiac index; CPB; cardiopulmonary bypass; ICU; intensive care unit; IL; interleukin; IS; inotropic score; LCOS; low cardiac output syndrome; T4; thyroxin; TISS; therapeutic intervention score; TT3
Keywords: اینترلوکین; AdV; adenovirus; ATP; adenosine triphosphate; APC; antigen presenting cell; CTLA-4; cytotoxic T lymphocyte antigen 4; CTL; cytotoxic T lymphocyte; CXCL/CCL; C-X-C motif ligands; DAMPs; damage-associated molecular pattern molecules; DC; dendritic cell; GIT
Keywords: اینترلوکین; AMPK; AMP-activated protein kinase; BLM; bleomycin; COX 2; cycloxigenase-2; EMT; epithelial mesenchymal transition; GPx; glutathione peroxidase; GST; gluthatione S transferase; HYP; hydroxyproline; IFN-α; interferon alpha; IL; interleukin; JAK-STAT; the
Keywords: اینترلوکین; T1DM; Type 1 diabetes mellitus; EDS; Search E-Resources; IGF1; insulin-like growth factor 1; NOD; non-obese diabetic; G6Pase; glucose-6-phosphatase; HGF; hepatocyte growth factor; SCID; severe combined immunodeficiency; BTC; betacellulin; Ngn3; Neurogenin
Keywords: اینترلوکین; autoinflammatory; recurrent fever; interleukin-1; FMF; Familial Mediterranean fever; IL; Interleukin; PFAPA; Periodic fever, aphthous stomatitis, pharyngitis, adenitis;
Keywords: اینترلوکین; H&E; hematoxylin and eosin; HPLC; high-performance liquid chromatography; IF; immunofluorescence; IL; interleukin; MT; Masson's trichrome; PBS; phosphate-buffered saline; PMN; polymorphonuclear cell; SEM; scanning electron microscope; TA; triamcinolone
Keywords: اینترلوکین; Cytokines; Glucose metabolism; IL-18; Inflammation; Neurofilament light; Okinawan-based Nordic diet; Type 2 diabetes; AD; Alzheimer's disease; CRP; C-reactive protein; E%; energy percent; HRQoL; health-related quality of life; HbA1c; hemoglobin A1c; IFN-Î
Keywords: اینترلوکین; APR; acute phase response; CNS; central nervous system; CXCL; C-X-C motif ligand; IL; interleukin; ICAM; intercellular adhesion molecule; P; postnatal day; LPS; lipopolysaccharide; PBS; phosphate-buffered saline; rrIL-1β; rat recombinant IL-1β; RT-qPCR;
Keywords: اینترلوکین; ADA; anti-drug antibodies; AMPK; 5â² adenosine monophosphate-activated protein kinase; aHUS; atypical hemolytic uremic syndrome; AMD; age-related macular degeneration; APC; antigen presenting cells; AT; anaphylatoxin; BTK; Bruton's tyrosine kinase; C1q
Keywords: اینترلوکین; SLE; systemic lupus erythematosus; RA; rheumatoid arthritis; C3; complement factor 3; IgM, IgG; IgA immunoglobulin M, G, A; APS; antiphospholipid syndrome; anti-Ro/SSA; anti-Sjögren syndrome-related antigen A; HF; heart failure; CVD; cardiovascular disea
Keywords: اینترلوکین; α-syn; alpha-synuclein; AA; appendicitis/appendectomy; CCR; C-C chemokine receptor; CD; Crohn's disease; CXCR C-X-C; chemokine receptor; DSS; dextran sulfate sodium; GALT; gastrointestinal lymphoid tissue; IBD; inflammatory bowel disease; Ig; immunoglo
Keywords: اینترلوکین; AV; atrioventricular; CCL; chemokine C-C motif ligand; CCR; chemokine C-C motif receptor; CXCL; chemokine C-X-C motif ligand; CX3CR; chemokine C-X3-C motif receptor; ECM; extracellular matrix; GM-CSF; granulocyte macrophage colony-stimulating factor; HSC;
Keywords: اینترلوکین; Eosinophilic Esophagitis; Esophagitis; Esophagus; DIS; dilation of intercellular space; EoE; eosinophilic esophagitis; EREFS; edema, rings, exudates, furrows, and strictures; GERD; gastroesophageal reflux disease; HPF; high power field; IL; interleukin; P
Keywords: اینترلوکین; 8-OHdG; 8-hydroxy-2-deoxyguanosine; Îym; mitochondrial membrane potential; AMPK; AMP-activated protein kinase; apoB; apolipoprotein B; AST; aspartate transaminase; ALT; alanine transaminase; ATP; adenosine triphosphate; CPT-1; carnitine palmitoyl-transfe
Keywords: اینترلوکین; Early Life Adversity; Inflammatory Bowel Disease; Epinephrine; Histone Acetylation; NF-κB; AI; adult inflammation; ChIP; chromatin immunoprecipitation; Ctl; control; H4K12ac; acetylated HRK12; HDAC; histone deacetylase; IBD; inflammatory bowel disease; I
Keywords: اینترلوکین; adverse events; depression; mental health; psoriasis; psychiatric; psychiatry; suicidal ideation and behavior; AE; adverse event; C-SSRS; Columbia Suicide Severity Rating Scale; eC-SSRS; electronic Columbia Suicide Severity Rating Scale; HADS; Hospital An
Keywords: اینترلوکین; Ala; alanine; Arg; arginine; CR; caloric restriction; GH; growth hormone; GHR; growth hormone receptor; GHRH; growth hormone-releasing hormone; IGF-1; insulin-like growth factor 1; IL; interleukin; IKKα/β; inhibitor of nuclear factor kappa-B kinase α/Î
Keywords: اینترلوکین; ADAM; a disintegrin and metalloproteinase; AGT; angiotensinogen gene; AMD; age-related macular degeneration; ANG; angiopoietin; BDNF; brain-derived neutrotrophic factor; BW; birth weight; DR; diabetic retinopathy; eNOS; endothelial nitric oxide synthase;
Keywords: اینترلوکین; BBB; blood-brain barrier; CNS; central nervous system; CSF; cerebrospinal fluid; DCs; dendritic cells; EAE; experimental autoimmune encephalomyelitis; GFAP; glial fibrillary acidic protein; IFN; interferon; IL; interleukin; IVIG; intravenous immunoglobuli
Keywords: اینترلوکین; BF; bifenthrin; AB; antibody; BCA; bicinchoninic acid; BW; body weight; CNS; central nervous system; COX; cyclooxygenase; IL; interleukin; mPGES; microsomal prostaglandin E synthase; Nrf2; nuclear erythroid-2 like factor-2; NF-kB; nuclear factor kappa-lig
Keywords: اینترلوکین; Aβ; amyloid beta; AβO; Aβ oligomer; ACh; acetylcholine; AChE; acetylcholinesterase; AD; Alzheimer's disease; AGEs; advanced glycation end products; AND; age-related neurological disorder; Bax; Bcl-2-associated X protein; Bcl-2; B-cell lymphoma 2; BDNF;
Keywords: اینترلوکین; cAMP; cyclic adenosine monophosphate; GPCRs; G protein-coupled receptors; GLP-1; glucagon-like peptide 1; ATP; adenosine triphosphate; cGMP; cyclic guanosine monophosphate; Na+/K+/ATPase; sodium-potassium adenosine triphosphatase; TRPC; transient recept
Keywords: اینترلوکین; CCL; chemokine (CC-motif) ligand; CD; cluster of differentiation; CXCL; chemokine (CXC-motif) ligand; IL; interleukin; KD; knock-down; KO; knock-out; LPS; lipopolysaccharide; NT; non-target; PC; proprotein convertase; STAT; signal transducer and activator
Keywords: اینترلوکین; Murine Models of Food Allergy; Epictutaneous Sensitization; Spontaneous Sensitization; Humanized Model; FCERIA; IgE; Anaphylaxis; Allergen Sensitization; Allergen Challenge; EPIT; epicutaneous immunotherapy; FCER1A; high-affinity immunoglobulin epsilon re
Keywords: اینترلوکین; allogeneic stem cell transplantation; apheresis; chemokine; granulocyte colony-stimulating factor; hematopoietic stem cell mobilization; interleukin; peripheral blood stem cell grafts; plasma profile; protease; soluble adhesion molecule;